IART Q4 2020 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$389M-1.6% YoY

Gross Profit

$242M62.2% margin

Operating Income

$53M13.5% margin

Net Income

$93M23.9% margin

EPS (Diluted)

$1.09

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

$80M

Free Cash Flow

$72M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.6B

Total Liabilities

$2.1B

Stockholders' Equity

$1.5B

Cash & Equivalents

$470M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$389M	$395M	-1.6%
Gross Profit	$242M	$246M	-1.7%
Operating Income	$53M	$36M	+45.9%
Net Income	$93M	$15M	+505.4%

Revenue Segments

Codman Specialty Surgical

$254M65%

Orthopedics and Tissue Technologies

$134M35%

Geographic Segments

UNITED STATES

$277M71%

Europe

$49M13%

Asia Pacific

$43M11%

Rest Of World

$20M5%